Location History:
- Edison, NJ (US) (1997 - 1999)
- Somerset, NJ (US) (1999 - 2010)
Company Filing History:
Years Active: 1997-2010
Title: The Innovative Contributions of Sandra J Rattray
Introduction
Sandra J Rattray is a notable inventor based in Somerset, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of antiprotozoal agents. With a total of 9 patents to her name, her work has had a considerable impact on medical research and treatment options.
Latest Patents
Among her latest patents is the innovative work titled "Toxoplasma gondii cyclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents." This patent focuses on the isolation and cloning of protozoal cyclic GMP dependent protein kinases, which may be utilized in screening assays to identify potential antiprotozoal agents. Another significant patent is "Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents," which shares similar objectives and methodologies in the quest for effective treatments.
Career Highlights
Sandra has worked with prominent companies in the pharmaceutical industry, including Merck & Company, Inc. and Merial Limited. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Throughout her career, Sandra has collaborated with esteemed colleagues such as Dennis M Schmatz and Anne M Gurnett. These partnerships have fostered a collaborative environment that has led to innovative solutions in her area of expertise.
Conclusion
Sandra J Rattray's contributions to biotechnology and her innovative patents highlight her role as a leading inventor in the field. Her work continues to influence the development of new treatments for diseases, showcasing the importance of research and collaboration in advancing medical science.